Latin American regulatory reform boosts 20% growth in international trials
This article was originally published in Clinica
Executive Summary
The modernisation of clinical trial regulations in Latin America has contributed to a 20% rise in the number of international studies over the last four years, according to the US FDA's newsletter, Clinical Trials Advisor (October 16). Citing expert opinion, including from Wendy Buckland, vice-president of clinical development for Latin America at contract research organisation PPD, it reports that there are currently 323 trials (medtech and pharma) under way in Brazil, 292 in Mexico and 107 in Colombia.